MicroRNA ‐588 is upregulated in human prostate cancer with prognostic and functional implications

Conclusion: Aberrant upregulation of endogenous miR‐588 in PCa patients may be a prognostic biomarker, indicative of their poor clinical outcomes. Inhibiting endogenous miR‐588 may also serve as a therapeutic target for PCa treatment. This article is protected by copyright. All rights reserved

Source: Journal of Cellular Biochemistry - October 5, 2017 Category: Biochemistry Authors: Nan Zhao, Tao Lin, Changbo Zhao, Shikai Zhao, Shiming Zhou, Yuqiao Li Tags: Article Source Type: research